Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

NCT04882293 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia Associated With Type II Diabetes Mellitus

Interventions

DRUG: Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose
DRUG: Atorvastatin (Lipitor ®)

Sponsor

Laboratorios Silanes S.A. de C.V.